Viatris Inc Receivables Turnover Ratio (VTRS), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Viatris Inc   (NASDAQ: VTRS)
 

Viatris Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Viatris Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 4.77, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2026. Average receivable collection period, for the Viatris Inc in Sep 30 2026 quarter, has decreased to 77 days, compared to 78 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 386 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2722, from overall ranking in the second quarter 2026 at 3158.

What is Receivable Turnover Ratio?
What is Viatris Inc Selling?


What is Receivable Turnover Ratio?





VTRS Receivables Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Receivable Change -7.43 % -4.05 % -1.58 % -5.9 % -9.3 %
Y / Y Revenue Change -0.28 % 4.88 % 8.07 % 4.97 % 0.23 %
Receivable Turnover Ratio (TTM) 4.77 4.68 4.57 4.47 4.35
VTRS's Total Ranking # 2722 # 3158 # 2852 # 2924 # 2994
Accounts Receivable average collection period days 77 78 80 82 84
Seq. Receivable Change -0.16 % 1.62 % 1.48 % -10.09 % 3.48 %
Seq. Revenue Change -0.19 % 6.82 % -5.04 % -1.5 % 4.96 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 116
Healthcare Sector # 387
Overall Market # 2722

Receivable Turnover Ratio Statistics
High Average Low
6.91 4.48 4.06
(Jun 30 2021)   (Dec 31 2021)




  News about Viatris Inc Receivables Turnover Ratios

Navigating Financial Straits Viatris Inc.s Improving Receivables Amidst Sector Challenges,

Navigating Financial Straits: Viatris Inc. s Improving Receivables Amidst Sector Challenges In the fast-evolving landscape of pharmaceutical sciences, fiscal resilience stands as a paramount pillar for sustained success. Viatris Inc. (NASDAQ: VTRS), a notable player in this realm, has recently been spotlighted with significant financial developments that warrant attention from its shareholders and the wider investment community. As April 2025 unfolds, an important notice from The Gross Law Firm serves as a clarion call to those vested in Viatris, urging them to deliberate over their rights before the looming deadline of June 3, 2025.At the heart of this narrative lies Viatris’ capacity to manage its accounts receivable, particularly from its corporate clients a key indicator of its fiscal health and operational efficiency. In the fourth quarter of 2024, the company demonstrated a noteworthy improvement in its ability to collect outstanding accounts receivable, with the collection ratio rising to 4.17. Although this figure falls below the company’s historical average, it offers a beacon of cautious optimism amidst a challenging business environment.




Financial Statements
Viatris Inc 's Accounts Receivable $ 3,121 Millions Visit VTRS's Balance sheet
Viatris Inc 's Sales TTM $ 14,727 Millions Visit VTRS's Income Statement
Sources of VTRS's Revenues Visit VTRS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VTRS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VTRS's Growth Rates VTRS's Roa VTRS's Inventory Turnover Ratio VTRS's Dividend Comparisons
VTRS's Profitability Ratios VTRS's Roi VTRS's Asset Turnover Ratio VTRS's Dividend Growth
VTRS's Valuation Ratios VTRS's Roe VTRS's Financial Strength Ratios VTRS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Biodesix Inc   11.45 $ 105.212  Millions$ 9.192  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Pediatrix Medical Group Inc   8.57 $ 1,959.124  Millions$ 228.471  Millions
Tenet Healthcare Corp  8.54 $ 22,154.000  Millions$ 2,593.250  Millions
Brightspring Health Services Inc   8.50 $ 9,479.144  Millions$ 1,114.763  Millions
Sotera Health Company  8.49 $ 1,230.250  Millions$ 144.974  Millions
Acadia Pharmaceuticals Inc   8.46 $ 1,202.301  Millions$ 142.117  Millions
Tactile Systems Technology Inc   8.23 $ 357.176  Millions$ 43.385  Millions
Penumbra Inc  8.22 $ 1,560.334  Millions$ 189.735  Millions
Inspire Medical Systems inc   8.15 $ 882.194  Millions$ 108.207  Millions
Adapthealth Corp   8.14 $ 3,152.043  Millions$ 387.280  Millions
Rhythm Pharmaceuticals Inc   8.03 $ 280.748  Millions$ 34.950  Millions
Alphatec Holdings Inc   7.91 $ 839.652  Millions$ 106.153  Millions
Exelixis Inc   7.89 $ 2,496.861  Millions$ 316.636  Millions
Henry Schein Inc   7.84 $ 13,734.000  Millions$ 1,752.000  Millions
Idexx Laboratories Inc  7.78 $ 4,663.675  Millions$ 599.701  Millions
Madrigal Pharmaceuticals Inc   7.70 $ 1,427.940  Millions$ 185.380  Millions
Pulmonx Corporation  7.56 $ 89.176  Millions$ 11.791  Millions
Merit Medical Systems Inc  7.53 $ 1,612.236  Millions$ 214.065  Millions
Cerus Corporation  7.48 $ 226.798  Millions$ 30.308  Millions
Insmed Inc  7.45 $ 1,479.040  Millions$ 198.502  Millions
Novocure Limited  7.44 $ 725.388  Millions$ 97.525  Millions

Date modified: 2026-11-06T13:03:53+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.